Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03491462
What this trial is testing

Arimoclomol in Amyotropic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
ZevraDenmark 245
Very early researchStudy completedNCT02710162
What this trial is testing

Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Florida 21
Testing effectiveness (Phase 2)Ended earlyNCT03334786
What this trial is testing

Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS

Who this might be right for
Amyotrophic Lateral SclerosisFasciculation
Flex Pharma, Inc. 3
Not applicableLooking for participantsNCT04885374
What this trial is testing

China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine

Who this might be right for
Amyotrophic Lateral Sclerosis
Dongzhimen Hospital, Beijing 2,000
Testing effectiveness (Phase 2)Study completedNCT01089010
What this trial is testing

CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 67
Not applicableStudy completedNCT02611674
What this trial is testing

Methodology Study of Novel Outcome Measures to Assess Progression of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 138
Testing effectiveness (Phase 2)Study completedNCT05039268
What this trial is testing

3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Macquarie University, Australia 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05218668
What this trial is testing

Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)

Who this might be right for
Amyotrophic Lateral Sclerosis
Woolsey Pharmaceuticals 40
Not applicableLooking for participantsNCT06820008
What this trial is testing

Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neurone Disease
University of Dublin, Trinity College 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07321860
What this trial is testing

This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic Signaling

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Gipfel Life Sciences GmbH 60
Not applicableLooking for participantsNCT07491484
What this trial is testing

Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
TidalHealth, Inc. 30
Not applicableLooking for participantsNCT04097158
What this trial is testing

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

Who this might be right for
Amyotrophic Lateral Sclerosis
Loma Linda University 160
Testing effectiveness (Phase 2)Ended earlyNCT04066244
What this trial is testing

Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Novartis Pharmaceuticals 28
Early research (Phase 1)Active Not RecruitingNCT05306457
What this trial is testing

CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Cedars-Sinai Medical Center 16
Not applicableStudy completedNCT00714636
What this trial is testing

Cerebrospinal Fluid Repository

Who this might be right for
Amyotrophic Lateral SclerosisCerebrospinal FluidNeurodegenerative Disease+1 more
Drexel University College of Medicine 11
Not applicableActive Not RecruitingNCT07143656
What this trial is testing

Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders
Biocells Medical 36
Not applicableStudy completedNCT00716131
What this trial is testing

Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program

Who this might be right for
Amyotrophic Lateral SclerosisNeurodegenerative DiseaseMotor Neuron Disease
Drexel University College of Medicine 205
Not applicableStudy completedNCT00956501
What this trial is testing

Assessment of Postural Orientation and Equilibrium In Early Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Wake Forest University Health Sciences 35
Large-scale testing (Phase 3)Looking for participantsNCT03127267
What this trial is testing

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
AB Science 495
Early research (Phase 1)Study completedNCT03241784
What this trial is testing

Ph1 T-Regulatory Cells in Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
The Methodist Hospital Research Institute 3
Next Page